diltiazem has been researched along with Leukemia P388 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, Y; Hui, PZ; Mino, M; Tatsumi, K; Yamamoto, S | 1 |
| Dekker, K; Kojima, N; Mino, M; Tatsumi, K; Yagi, K; Yamamoto, S | 1 |
2 other study(ies) available for diltiazem and Leukemia P388
| Article | Year |
|---|---|
Potentiation of harringtonine cytotoxicity by calcium antagonist diltiazem and biscoclaurine alkaloid cepharanthine in adriamycin-resistant P388 murine leukemia and K562 human leukemia cells.
Topics: Alkaloids; Animals; Benzylisoquinolines; Biological Transport; Cell Count; Cell Line; Cell Survival; Diltiazem; Doxorubicin; Drug Resistance; Growth Inhibitors; Harringtonines; Humans; Leukemia P388; Leukemia, Experimental; Vincristine | 1989 |
A simple fluorometric method to discriminate adriamycin-resistant subline from adriamycin-sensitive parental P388 murine leukemia cell line.
Topics: Animals; Diltiazem; Doxorubicin; Drug Resistance; Leukemia P388; Leukemia, Experimental; Mice; Spectrometry, Fluorescence; Tamoxifen; Time Factors; Tumor Cells, Cultured; Vincristine | 1987 |